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Purpose: To investigate the suitability of the linear-quadratic (LQ) and universal survival curve   
(USC) models in describing the 3-year tumor control probability (TCP) data from stage I non-small
cell lung cancer (NSCLC) patients treated with carbon ion radiotherapy given at a total dose of   
59.4-95.4 Gy[RBE] in 18 fractions, 72 Gy[RBE] in 9 fractions, 52.8-60 Gy[RBE] in 4 fractions   
and 28-50 Gy[RBE] in a single fraction.  
 
Materials and Methods: A meta-analysis of published clinical data from 394 patients presenting  
with early stage NSCLC was conducted. TCP modeling based on the LQ and USC models was  p
erformed by simultaneously fitting the clinical data obtained from the different fractionation sche- du
les while considering several spread-out Bragg peak (SOBP) sizes. Radiobiological parameters   wer
e derived from the fit. Based on the results, a novel SOBP was created for the single fraction regi
men that was optimized with respect to the USC model aimed at achieving a 95% local cont- rol.
  
 
Results: The USC model gave a better fit to the 3-year local control data. The fit using various  
SOBP sizes yielded transition doses between 5.6-7.0 Gy. The results also revealed α/β ratios bet-  
ween 7.4-9.1 Gy and 7.4-9.4 Gy for the LQ and USC models, respectively.  
 
Conclusions: The USC model provided a better estimate of the local control rate for the single   f
raction course. For the schemes with more number of fractions, the local control rate estimates  
from the LQ and USC models were comparable. A USC-based SOBP design was then created for 
the single fraction schedule.  The updated design resulted in a flatter RBE profile compared to thec
onventional SOBP design. It also gave a better clinical dose prediction to optimize the tumor con-tr
ol rate.                                                                       
